Cequint, Inc. – Trademark Portfolio

Entity Type: 03

Cequint, Inc. holds 18 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 16 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include CEQUINT and CITY ID. The owner is based in Seattle, WA.

1525 Fourth Avenue

Suite 700

Seattle, WA 98101

18 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Cequint, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (16 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

42
Computer & Scientific (8 filings)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does Cequint, Inc. have?

Cequint, Inc. has 18 U.S. trademarks filed with the USPTO. Of these, 3 registered, 14 abandoned, 1 cancelled.

What trademark classes does Cequint, Inc. file in?

Cequint, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Cequint, Inc.'s most well-known trademarks?

Cequint, Inc.'s registered trademark portfolio includes well-known marks such as CEQUINT and CITY ID. These are among 3 currently registered trademarks in the portfolio.

What is Cequint, Inc.'s trademark registration success rate?

Cequint, Inc. has a 17% trademark registration rate, with 3 out of 18 resolved applications resulting in successful registration. Currently, 0 applications are pending review.